OZZZER AI NEWS · Unite.AI

Every Cure Taps OpenEvidence to Advance Noncommercial Drug Repurposing

16 Nov 2026

Every Cure Taps OpenEvidence to Advance Noncommercial Drug Repurposing

Every Cure announced a partnership with OpenEvidence on November 16, 2026, to advance new uses for existing medicines where commercial incentives are lacking, linking AI-supported drug evaluation with specialist input, clinical-trial recruitment and evidence distribution to physicians.

Join free to read this story

Join for OZZZER previews and reviewed analysis. The full publisher article may require a separate subscription.

Join free to open original ↗